RSS

Recipharm

Global contract development and manufacturing organisation (CDMO) Recipharm has joined the AMR Industry Alliance to help tackle growing concerns around antimicrobial resistance (AMR). Read more

News

Contract development and manufacturing organisation (CDMO) Recipharm has launched an integrated end-to-end inhalation offering for its customers. Read more

News

Here EPM speaks to a number of major pharma players to get their thoughts on what FMD means for the industry. Read more

Opinion

Contract development and manufacturing organisation (CDMO) Recipharm has announced that all of its facilities are ready for EU serialisation. Read more

News

European Pharmaceutical Manufacturer speaks to some of the leading names in pharmaceutical manufacturing to find out what the key moments have been for them in 2018. Read more

Opinion

Torkel Gren, Recipharm and Anders Millerhovf, CTC Clinical Trial Consultants discuss the steps needed for drug formulation during first-in-human (FIH) trials, if regulatory approval is to be achieved. Read more

, Opinion

Five non-critical highly potent products supplied by contract development and manufacturing organisation (CDMO) Recipharm have had their manufacturing licence restricted. Read more

News

As we draw ever nearer to the time that compliance with the European Falsified Medicines Directive (FMD) is required, we discuss the value of serialisation beyond compliance and outsourcing with six leading solutions providers. Read more

Latest Issue

Contract development and manufacturing organisation (CDMO) Recipharm has received approval by the European Medicines Verification Organisation (EMVO) to submit serialisation data to the European Hub. Read more

News

In this interview, we at EPM magazine speak with Staffan Widengren, director of corporate projects at Recipharm on the difficulties CDMOs are facing leading up to the European Falsified Medicines Directive (EU FMD) deadline in February 2019. Read more

Opinion

Last week, the UK government saw heated debates and closely contested votes on the post-Brexit strategy, including a favourable outcome for the future relationship of the UK and the European Medicines Agency (EMA) Read more

News

Now we have just passed the six-month marker (1 July) until the European Medicines Agency (EMA) moves from its current location in London to Amsterdam, as a result of Brexit, we gauge industry response to this change… Read more

Opinion

CDMO, Recipharm, has acquired Sanofi’s manufacturing centre and business located in Holmes Chapel, which will provide the company with a platform to take advantage of the growing respiratory drug market. Read more

News

Contract development and manufacturing organisation (CDMO), Recipharm, has partnered with Hadasit Medical Research Services and Development to deliver combined clinical, biological and chemical services. Read more

News

Contract development and manufacturing organisation (CDMO), Recipharm, has been recognised in the CMO Leadership Awards for 2018, organised by Life Science Leader. Read more

News

Contract development and manufacturing organisation (CDMO), Recipharm, has revealed that the winner of its 2017 International Environmental Award is Karen Kidd Read more

News

Contract development and manufacturing organisation (CDMO), Recipharm, has signed a licensing agreement with Canadian drug development company, Altus Formulation, to offer new drug delivery technologies for value added medicines. Read more

Technology

Today (Friday 9 Feburary 2018) marks the precise point that we are a year away until the European Union Falsified Medicines Directive (EU FMD) comes into force. Here, we feature some expert opinions Read more

Opinion

Recipharm has taken a step further in its development and growth in the Indian market by acquiring the remaining shares in Nitin Lifesciences. Read more

News

Mark Quick, executive vice president of corporate development, Recipharm, goes into detail about the opportunities his company has faced this year as well as the challenges. Read more

Opinion